# Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation

> **NCT05508841** · NA · RECRUITING · sponsor: **Baycrest** · enrollment: 42 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **OTHER:** tDCS and Cognitive Training

## Key facts

- **NCT ID:** NCT05508841
- **Lead sponsor:** Baycrest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508841, "Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05508841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*